跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SANDOZ AMOXI-CLAV TABLET - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
SANDOZ AMOXI-CLAV TABLET
Authorized
STANDARD
SANDOZ AMOXI-CLAV TABLET
Sandoz Canada, Inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
e31f30a6f3dd38dd
Company
Sandoz Canada, Inc.
Type
Standard
Approval Details
Approval Id
e31f30a6f3dd38dd
Drug Approval Canada Name
SANDOZ AMOXI-CLAV TABLET
Product Name
SANDOZ AMOXI-CLAV TABLET
Status
Marketed
Status Date
2019-03-01
Original Market Date
2019-03-01
Din
02482576
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
08:12.16.08
Atc Original
J01CR02 AMOXICILLIN AND BETA-LACTAMASE INHIBITOR
Atc Name
j 01 cr 02
Aig Number
0234720009
Company Name
Sandoz Canada, Inc.
Company Address
4600 Rue Armand-Frappier, Saint-Hubert, Quebec, Canada, J3Z 1G5
Company Detail Path
/organization/sandoz-canada-inc
Company Information
Pharmaceutical Company Name
Sandoz Canada, Inc.
Country Name
Canada
Website
http://www.sandoz.ca
Active Ingredients
AMOXICILLIN (AMOXICILLIN TRIHYDRATE)
500 MG
CLAVULANIC ACID (CLAVULANATE POTASSIUM)
125 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
e31f30a6f3dd38dd
Type
Standard
Back to Health Canada Approvals